An episode of subacute encephalopathy after the infusion of a moderate dose of methotrexate (1500 mg/m2) (MTX) is reported in a young adult with metastastic gastric cancer.
She continued to receive regular insulin 4 times per day over the following 3 years with only occasional hives.